FIELD: pharmacology; dermatology; anti-aging medicine.
SUBSTANCE: disclosed is the use of echinochrome A as an agent with inhibitory activity against matrix metalloproteinases 1 and 2 (MMP 1 and MMP 2), tryptase and chymase.
EFFECT: protection of skin against photoaging.
1 cl, 8 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2022 |
|
RU2794841C1 |
| TREATING AND/OR PREVENTING SKIN INFLAMMATION AND PHOTOPATHY AND SKIN PHOTOPROTECTION BY MEANS OF WATER-SOLUBLE HERBAL EXTRACT OF SOLANUM | 2012 |
|
RU2541804C2 |
| COMPOSITIONS AND METHODS OF SKIN CARE | 2009 |
|
RU2517594C2 |
| ANTIOXIDANT COMPOSITIONS AND METHODS FOR USE THEREOF | 2014 |
|
RU2654804C2 |
| NEW DOSAGE FORM OF ECHINOCHROME A, A METHOD OF ITS PREPARATION AND USE | 2022 |
|
RU2800382C1 |
| WAY OF CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2359686C2 |
| COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
| CORRECTIVE COMPOSITION FOR PATHOLOGIC CARBOHYDRATE, LIPID DISBOLISM AND ANTIOXIDANT ORGANISM STATE INVOLVEMENT | 2008 |
|
RU2360683C1 |
| COMPOSITIONS SUITABLE TO TREAT DERMAL SIGNS OF AGING | 2005 |
|
RU2409290C2 |
| ANTISENSE OLIGONUCLEOTIDES OF MATRIX METALLOPROTEINASE-1 | 2019 |
|
RU2802418C2 |
